POTASSIUM 4-CHLOROPHENYLTRIFLUOROBORATE
Product Information
Molecular Formula
C6H4BClF3K
Molecular Weight
218.45
Description
POTASSIUM 4-CHLOROPHENYLTRIFLUOROBORATE is a widely utilized compound within the biomedical industry and holds paramount importance as a reagent in the synthesis and alteration of multifarious pharmaceutical drugs. Its diverse traits render it a valuable asset in the therapeutic intervention of an array of ailments, encompassing cancer, inflammation, and neurodegenerative disorders.
Synonyms
POTASSIUM 4-CHLOROPHENYLTRIFLUOROBORATE; Potassium 4-chlorophenyltrifluoroborate,97%
IUPAC Name
potassium(4-chlorophenyl)-trifluoroboranuide
SMILES
[B-](C1=CC=C(C=C1)Cl)(F)(F)F.[K+]
InChI
InChI=1S/C6H4BClF3.K/c8-6-3-1-5(2-4-6)7(9,10)11/h1-4H/q-1+1
InChI Key
GXBSKMLVYJPMRT-UHFFFAOYSA-N
Melting Point
>300 °C (lit.)
Purity
95%
Appearance
White powder
Safety Information
Hazards
H315-H319-H335
Precautionary Statement
P261-P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
217.9683740 g/mol
Monoisotopic Mass
217.9683740 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
12
Formal Charge
0
Complexity
133
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113150018-A | Four-coordination N, N-chelating monoaryl monofluoroborate compound and preparation method thereof | 2021-02-26 |
| CN-111620896-A | Preparation method of tetra-coordinated N, N-chelated diaryl borate compound with 8-aminoquinoline derivative as bidentate ligand | 2020-06-11 |
| CN-110256306-B | Ortho-sulfonamide substituted diaryl iodine compound and preparation method and application thereof | 2019-06-27 |
| AU-2016354661-A1 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors | 2015-11-13 |
| CA-3004680-A1 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors | 2015-11-13 |
| EP-3374360-A1 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors | 2015-11-13 |
| JP-2019504108-A | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors | 2015-11-13 |
| KR-20180097542-A | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of Group II metabotropic glutamate receptors | 2015-11-13 |
| US-2018346468-A1 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors | 2015-11-13 |
| WO-2017081483-A1 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors | 2015-11-13 |
